Member Login
  1. Stocks
    2. /
  2. Dechra Pharmaceuticals PLC (LSE: DPH)
    3. /

LSE:DPH (Dechra Pharmaceuticals PLC)

About DPH

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. It listed in London in 2000.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Dechra Pharmaceuticals PLC (LSE: DPH) Latest News

    Investing Articles

    No savings at 40? I’d buy these 2 fast-growing FTSE 100 stocks to top up the State Pension

    | Harvey Jones

    These two stocks offer growth today and protection in case of a market correction, in my opinion.

    Read more »

    Investing Articles

    ISA investors! A dividend growth stock I’d buy for 2020 and hold for the next decade!

    | Royston Wild

    Forget about some of the FTSE 100's healthcare giants! Royston Wild picks out a FTSE 250 operator in the box…

    Read more »

    Investing Articles

    I tipped these 2 FTSE 250 stocks to outperform in 2019. Next year looks promising too

    | Harvey Jones

    Harvey Jones says these FTSE 250 (INDEXFTSE:UKX) have shown their worth in 2019.

    Read more »

    Investing Articles

    £6k to invest? These three growth champions are my top buys for 2020!

    | Rupert Hargreaves

    These growth champions dominate their respective markets and should continue to beat them for many years to come, argues Rupert…

    Read more »

    Retirement Articles

    A top dividend growth stock I’d buy for my retirement fund in 2020

    | Royston Wild

    Royston Wild reveals a top income buy for 2020 and beyond. Why not take a look?

    Read more »

    Retirement Articles

    Forget GlaxoSmithKline! 2 ‘better’ pharmaceutical stocks I think could help you retire in luxury

    | Royston Wild

    Sure, GlaxoSmithKline plc (LON: GSK) has delivered some pretty decent shareholder returns over the past half a decade. But are…

    Read more »

    Investing Articles

    Expensive but exceptional! 3 FTSE 250 growth shares that could help you to retire early

    | Royston Wild

    These FTSE 100 (INDEXFTSE: UKX) stocks may be expensive but they're worth every penny, argues Royston Wild.

    Read more »

    Investing Articles

    Want to get rich? 3 FTSE 250 growth stocks that I’d buy and hold for the next 10 years

    | Royston Wild

    These growth giants from the FTSE 250 (INDEXFTSE: MCX) look set to thrive through the next 10 years at least,…

    Read more »

    Investing Articles

    I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

    | Harvey Jones

    Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year.

    Read more »

    Investing Articles

    2 FTSE 250 dividend stocks I’d buy and hold for 25 years

    | Royston Wild

    Royston Wild zeroes in on two terrific FTSE 250 (INDEXFTSE: MCX) income heroes that could make you richer.

    Read more »

    Investing Articles

    GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now

    | Kevin Godbold

    Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm.

    Read more »

    Investing Articles

    Top shares for September

    | The Motley Fool Staff

    We asked our writers to share their top stock picks for the month.

    Read more »